Last reviewed · How we verify
NCT03591640
The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage
NA trial testing Blood test in Fetal-Maternal Hemorrhage in 27 participants. Completed in 28 April 2021.
28 April 2021
Quick facts
| Lead sponsor | Hillel Yaffe Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 27 |
| Start date | 18 July 2018 |
| Primary completion | 28 April 2021 |
| Estimated completion | 28 April 2021 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Blood test — full drug profile →
Conditions studied
- Fetal-Maternal Hemorrhage — all drugs for Fetal-Maternal Hemorrhage →
Sponsor
Hillel Yaffe Medical Center
Who can join
18 and older, female only, with Fetal-Maternal Hemorrhage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03591640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood test
Trials testing the same drug.
- NCT06863974 — High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Im · NA · recruiting
- NCT07078435 — Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis · NA · not yet recruiting
- NCT05370300 — SNAPS Breast Cancer Patient Study Breast Cancer Patients · not yet recruiting
- NCT06820450 — Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis · not yet recruiting
- NCT06999785 — Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperba · NA · recruiting
Other Hillel Yaffe Medical Center trials
Trials by the same sponsor.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07134985 — Pediatric Patients Who Leave the Emergency Department Without Treatment · recruiting
- NCT06927193 — Regional Analgesia at the Pediatric Emergency Department · recruiting
- NCT07233525 — Home-Based Language and Cognitive Intervention for Arab Toddlers in Israel · NA · not yet recruiting
- NCT07320339 — The Aim of the Study is to Examine the Variation in Blood Pressure Between an Optimal Measurement (According to Establis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03591640 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hillel Yaffe Medical Center
- Last refreshed: 28 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03591640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing